Lung Transplantation in Patients With COVID-19-The Early National Experience

Uptake and 1-year outcomes of lung transplantation for COVID-19

“… 3 As COVID-19 transitions from a pandemic to an endemic disease, data regarding the outcomes of transplants for this indication are needed. The addition of COVID-19-specific diagnosis codes to national transplant registry data have assisted these efforts, 4 allowing evaluation of COVID-19–related LT outcomes on a national scale.…”

“… 5 However, these reports were limited to case series, 5 , 6 , 7 , 8 , 9 small national cohorts including fewer than 20 COVID-19-related LTs, 10 , 11 or short follow-up time points. 4 Florissi and colleagues 4 published one of the most comprehensive comparisons to date, finding that recipients of LT for an indication of COVID-19 had similar 90-day survival to non–COVID-19 ARDS LT recipients. However, their use of a historical cohort of ARDS patients from 2009 to 2022 and low sample size resulted in limited power and comparability to current COVID-19 LT outcomes.…”